Explore approved biosimilar medicines
| # | Medicine | Status | Active Substance | Therapeutic Area | Developer | Published Date |
|---|---|---|---|---|---|---|
| 151 | Stimufend | Authorised | pegfilgrastim | Fresenius Kabi Deutschland GmbH | 24-01-2022 | |
| 152 | Silapo | Authorised | epoetin zeta | Anemia;Blood Transfusion, Autologous;Cancer;Kidney Failure, Chronic | Stada Arzneimittel AG | 26-09-2017 |
Ready to transform your strategic intelligence? Let's talk
Get latest pharmaceutical insights, blogs, and strategic updates directly in your inbox.